Drug intelligence / Profile preview

cycloastragenol

Development stage
Preclinical
Lead developer
TA Sciences
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Cycloastragenol is a triterpenoid saponin aglycone derived from Astragalus species, particularly *Astragalus membranaceus*, a plant widely used in Traditional Chinese Medicine. It is recognized for its potential anti-aging properties and broad pharmacological effects. Cycloastragenol acts primarily as a telomerase activator—promoting the maintenance and elongation of telomeres—which are protective caps at the ends of chromosomes associated with cellular aging. Additional reported activities include antioxidative and anti-inflammatory effects, improvement of lipid metabolism, enhancement of immune function (notably in CD8+ T lymphocytes), promotion of wound repair, inhibition of endoplasmic reticulum stress-associated inflammasome activation (TXNIP/NLRP3), and possible neuroprotective actions such as axon regeneration after spinal cord injury. Cycloastragenol is efficiently absorbed via passive diffusion through the intestinal epithelium but undergoes significant first-pass hepatic metabolism that may limit its oral bioavailability[1][2][3][4][7][8]. Clinical research suggests it is relatively safe within certain dose ranges; however, herb-drug interactions and long-term safety require further study.

Other names
AstramembrangeninCyclogalegigeninCyclosieversigeninCyclosiversigenin
02

Targets

CYP2E1TERT (Telomerase)FXR (Farnesoid x-activated receptor)CREB (Cyclic AMP response element-binding protein)CTSB (Cathepsin B)CYP3A4 (Cytochrome P450 3A4)TXNIP (Thioredoxin-interacting protein)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on cycloastragenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cycloastragenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call